Concord Drugs Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Concord Drugs Ltd. on BSE

Load latest

Concord Drugs Ltd.

08 Aug 2025

66.00

-1.48%

Result

Concord Drugs Ltd - 538965 - Financial Results For Quarter Ending 30, June, 2025

BSE India

Quarter-1 results for FY 2025-2026

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	13.61	10.40	11.69	30.9%	16.4%
Operating Profit Qtr	1.02	1.04	0.83	-1.9%	22.9%
Net Profit Qtr	0.12	0.04	0.03	200.0%	300.0%
Earning Per Share Adjusted latest Qtr	0.12	0.04	0.03	200.0%	300.0%

* Consolidated data

Detailed Results

Concord Drugs Ltd.

08 Aug 2025

66.00

-1.48%

Board Meeting

Concord Drugs Ltd - 538965 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Board has approved unaudited financial results for first quarter ending 30, June, 2025.

pdf

Concord Drugs Ltd.

01 Aug 2025

66.00

-1.48%

Board Meeting

Concord Drugs Ltd - 538965 - Board Meeting Intimation for Quarterly Results

BSE India

Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and approve Un-audited financial results for quarter ending 30, June, 2025 and any other matter with the permission of chair

pdf